Literature DB >> 1982347

A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury.

Ze'ev Seltzer1, Ronald Dubner, Yoram Shir.   

Abstract

Partial nerve injury is the main cause of causalgiform pain disorders in humans. We present here a novel animal model of this condition. In rats we unilaterally ligated about half of the sciatic nerve high in the thigh. Within a few hours after the operation, and for several months thereafter, the rats developed guarding behavior of the ipsilateral hind paw and licked it often, suggesting the possibility of spontaneous pain. The plantar surface of the foot was evenly hyperesthetic to non-noxious and noxious stimuli. None of the rats autotomized. There was a sharp decrease in the withdrawal thresholds bilaterally in response to repetitive Von Frey hair stimulation at the plantar side. After a series of such stimuli in the operated side, light touch elicited aversive responses, suggesting allodynia to touch. The withdrawal thresholds to CO2 laser heat pulses were markedly lowered bilaterally. Suprathreshold noxious heat pulses elicited exaggerated responses unilaterally, suggesting thermal hyperalgesia. Pin-prick evoked such exaggerated responses bilaterally (mechanical hyperalgesia). In a companion report, we show that these abnormalities critically depend on the sympathetic outflow. Based on the immediate onset and long-lasting perpetuation of similar symptoms, such as touch-evoked allodynia and hyperalgesia, and the resemblance of the contralateral phenomena to 'mirror image' pains in some humans with causalgia, we suggest that this preparation may serve as a model for syndromes of the causalgiform variety that are triggered by partial nerve injury and maintained by sympathetic activity.

Entities:  

Mesh:

Year:  1990        PMID: 1982347     DOI: 10.1016/0304-3959(90)91074-S

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  347 in total

1.  Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.

Authors:  F Porreca; S E Burgess; L R Gardell; T W Vanderah; T P Malan; M H Ossipov; D A Lappi; J Lai
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

Review 2.  Role of the sympathetic nervous system in chronic joint pain and inflammation.

Authors:  B L Kidd; S Cruwys; P I Mapp; D R Blake
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

Review 3.  Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

4.  TRPV1-lineage neurons are required for thermal sensation.

Authors:  Santosh K Mishra; Sarah M Tisel; Peihan Orestes; Sonia K Bhangoo; Mark A Hoon
Journal:  EMBO J       Date:  2010-12-07       Impact factor: 11.598

5.  Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain.

Authors:  Yuri Kato; Miki Hiasa; Reiko Ichikawa; Nao Hasuzawa; Atsushi Kadowaki; Ken Iwatsuki; Kazuhiro Shima; Yasuo Endo; Yoshiro Kitahara; Tsuyoshi Inoue; Masatoshi Nomura; Hiroshi Omote; Yoshinori Moriyama; Takaaki Miyaji
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

6.  Extraction and characterization of essential discharge patterns from multisite recordings of spiking ongoing activity.

Authors:  Riccardo Storchi; Gabriele E M Biella; Diego Liberati; Giuseppe Baselli
Journal:  PLoS One       Date:  2009-01-28       Impact factor: 3.240

7.  Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury.

Authors:  Keiko Takasu; Motoko Honda; Hideki Ono; Mitsuo Tanabe
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 8.  Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.

Authors:  J Guindon; A G Hohmann
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

Review 9.  Towards a theory of chronic pain.

Authors:  A Vania Apkarian; Marwan N Baliki; Paul Y Geha
Journal:  Prog Neurobiol       Date:  2008-10-05       Impact factor: 11.685

10.  Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain.

Authors:  Ji Zhang; Xiang Qun Shi; Stefania Echeverry; Jeffrey S Mogil; Yves De Koninck; Serge Rivest
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.